Subscribe
Career Advice  

Funding News: 23 October 2009

In This Issue:

New Research Funding Programs

Alliance for Academic Internal Medicine.

ADA-ASP Young Investigator Innovation Award in Geriatric Endocrinology

In partnership with the American Diabetes Association, the Association of Specialty Professors offers the ADA-ASP Young Investigator Innovation Award in Geriatric Endocrinology. The 2-year $150,000 award funds the early stages of career development for an endocrinologist with a focus on diabetes who is interested in geriatric medicine. The award supports entry-level faculty members to integrate geriatrics with novel basic, clinical, or health services diabetes research. In addition, ASP offers travel grants for recipients to attend two American Geriatrics Society Annual Scientific Meetings and one ADA meeting. ASP also offers funds for the recipient to visit either a geriatrician or an endocrinologist with a professional research background similar to the recipient's research focus and present on his or her research at the host's institution. Deadline: 2010-01-15

Alzheimer's Association.

U.S.-U.K. Young Investigator Exchange Fellowship

The U.S.-U.K. Young Investigator Exchange Fellowship provides a 3-year grant to fund quality scientific research into the causes, diagnosis, and treatment of Alzheimer's disease. The fellowship aims to address important research questions as well as to help and encourage promising scientists as they establish their careers within Alzheimer's research internationally. It is also hoped that by supporting meaningful scientific collaboration between scientists in the United Kingdom and the United States, there will be mutual benefit to the research output of both countries. In addition to an exchange of ideas, an important aim is to promote the learning of new experimental techniques and methodologies. The purpose of this fellowship is to provide new investigators with funding that will allow them to develop preliminary or pilot data, to test procedures, and to develop hypotheses on an international level. The intent is to support international early-career development that will lay the groundwork for future research grant applications to other international funding agencies and groups. Applications submitted to the U.S.-U.K. Young Investigator Exchange Fellowship must target defined areas of focus in the Alzheimer's Association 2010 program announcement to be considered responsive to the announcement. The research aims and priorities of the Alzheimer's Research Trust are available on the ART Web site. The U.S.-U.K. Young Investigator Exchange Fellowship requires the proposed project to be aligned with a main supervisor and institution that will commit to allow the awardee to fulfill the exchange component of the fellowship. Central to the proposed arrangement is a co-supervisor from the second country who is able to guarantee provision for the agreed duration of the visit, which can be from 1 to 12 months. The co-supervisor's institution must agree to confer visiting fellow status to the awardee to ensure the fellow is allowed access to resources and services at the visiting institution. Deadline: 2009-12-01

Alzheimer's Association.

Mentored New Investigator Research Grant to Promote Diversity (MNIRGD)

The Mentored New Investigator Research Grant to Promote Diversity (MNIRGD) is a 3-year award intended to be a research-based and mentoring investment to help close disparities between diverse and nondiverse investigator populations. The Alzheimer's Association feels strongly that the mentoring and involvement of diverse researchers in independently funded Alzheimer's research is a pressing need. MNIRGD is intended to enhance the capacity of diverse and nondiverse scientists to conduct basic, clinical, and social/behavioral research. The purpose of this competition is to provide underrepresented new investigators with mentored funding that will allow them to develop preliminary or pilot data, test procedures, and develop hypotheses. The intent is to support early-career development through mentorship that will lay the groundwork for future research grant applications to the National Institutes of Health, the National Science Foundation, and other funding agencies and groups, including future proposals to the Alzheimer's Association. All MNIRGD applications must target defined areas of focus for fiscal year 2010 (see Section II) to be considered responsive to the program announcement. The Alzheimer's Association anticipates funding up to five NIRGD/MNIRGD awards under this competition. Each MNIRGD award is limited to $170,000. A total of $150,000 will be awarded for costs related to the proposed research for up to 3 years (direct and indirect costs). Requests in any given year may not exceed $60,000 (direct and indirect costs). Indirect costs are capped at 10%. (Rent for laboratory/office space is expected to be covered by indirect costs paid to the institution.) The principal investigator must commit to a 50% effort toward the proposed project over the funding period. The remaining funds, $10,000 to the applicant and $10,000 to the primary mentor, will be awarded upon successful completion of the 3-year program. These additional funds are to be applied to sustaining ongoing research in the Alzheimer's field and will be awarded through the applicant's and mentor's institutions. Successful completion of the program includes, but is not limited to, reaching all demonstrable benchmarks listed above. Deadline: 2009-12-01

Alzheimer's Association.

New Investigator Research Grant to Promote Diversity

The New Investigator Research Grant to Promote Diversity (NIRGD) in Alzheimer's research is a 2-year award to investigators who are currently underrepresented at academic institutions in Alzheimer's or related dementias research. The objective of this award is to increase the number of highly trained investigators from diverse backgrounds whose basic, clinical, and social/behavioral research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to Alzheimer's and related dementias in general and in health disparities populations. The Alzheimer's Association recognizes the need to increase the number of underrepresented scientists participating in biomedical and behavioral research. The association anticipates that by providing these research opportunities, the number of underrepresented scientists entering and remaining in biomedical research careers in Alzheimer's disease will increase. The purpose of this program is to provide underrepresented new investigators with funding that will allow them to develop preliminary or pilot data, to test procedures, and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to the National Institutes of Health, the National Science Foundation, and other funding agencies and groups, including future proposals to the Alzheimer's Association. All NIRGD applications must target defined areas of focus outlined in the 2010 Program Announcement (see Section II). The association anticipates funding up to five NIRGD awards under this competition. Each NIRGD award is limited to $100,000 (direct and indirect costs) for up to 2 years. Requests in any given year may not exceed $60,000 (direct and indirect costs). Indirect costs are capped at 10%. (Rent for laboratory/office space is expected to be covered by indirect costs paid to the institution.) Deadline: 2009-12-01

Alzheimer's Association.

Non-Pharmacological Strategies to Ameliorate Symptoms of Alzheimer's Disease

The Alzheimer's Association is launching a new initiative to stimulate the scholarly investigation and development of nonpharmacological strategies to improve the care of persons with Alzheimer's disease and related disorders (ADRD). The association's request for applications (RFA) is aimed at the identification, validation, and investigation of nonpharmacological approaches to improve the care of older adults with ADRD. This includes the investigation of new approaches, extension of existing approaches, and development of methodological strategies to improve the conduct of clinical and translational research of nonpharmacological treatments of ADRD. The RFA is designed to enable preliminary pilot research or proof-of-principle studies that can provide data for further research support by other funding agencies. This RFA focuses on the science of conducting and evaluating nonpharmacological interventions for the treatment of ADRD, whether independently or in conjunction with pharmacological approaches. The association anticipates funding two nonpharmacological approaches for ADRD awards. Each award is limited to $400,000 (direct and indirect costs) for 2 to 3 years. Requests in any given year may not exceed $200,000 (direct and indirect costs). Indirect costs are capped at 10%. (Rent for laboratory/office space is expected to be covered by indirect costs paid to the institution.) Deadline: 2009-12-01

Alzheimer's Association.

Novel Pharmacological Strategies to Prevent Alzheimer's Disease

The Alzheimer's Association is launching a new initiative to stimulate the development of new pharmacological strategies to prevent or treat Alzheimer's disease. The association's request for applications (RFA) is aimed at the identification and validation of novel drug targets, the screening and development of drugs for such targets, and the evaluation of drug safety and efficacy, mostly at the preclinical level. The RFA is designed to enable preliminary pilot research or proof-of-principle studies that can provide data for further research support by other funding agencies. A number of drug targets have been identified in Alzheimer's, including proteases that cleave the amyloid precursor protein, aggregation of amyloid peptides, kinases that phosphorylate tau, tau aggregation, structural and biological properties of apolipoprotein E that differentiate it from more protective apoE isoforms, and inflammatory mediators. All of these targets are already being pursued in large, highly competitive drug-development programs. Drugs aimed at some of these targets are in advanced clinical trials; however, the long-term efficacy and safety of these drugs will remain unknown for many years to come. Therefore, the association aims to keep open the pipeline for new drugs with the potential to significantly improve the treatment and prevention of Alzheimer's, either as monotherapy or in combination with drugs that are or soon will be available. The association anticipates funding two awards in this category. Each award is limited to $400,000 (direct and indirect costs) for 2 to 3 years. Requests in any given year may not exceed $200,000 (direct and indirect costs). Indirect costs are capped at 10%. (Rent for laboratory/office space is expected to be covered by indirect costs paid to the institution.) Deadline: 2009-12-01

Applied BioPhysics Inc.

Applied BioPhysics Early Career Mini Grant

Applied BioPhysics would like to help young scientists obtain funding. The electric cell-substrate impedance sensing (ECIS) minigrant is aimed at early-career scientists who are applying for their first R01 grant. Applied BioPhysics will provide an ECIS instrument, ECIS arrays, and consultation for a researcher wanting to use ECIS technology to achieve their specific aims. Applied BioPhysics hopes that these tools will generate preliminary data to support the applicant’s R01 proposal. Interested scientists should submit their research plan along with a cover letter describing how they believe ECIS technology may be used to achieve their specific aims. Applied BioPhysics will evaluate proposals based on scientific merit, suitability with ECIS technology, and novelty. Applications are accepted on an ongoing basis. Applicants should apply 3 to 6 months before their intended submission date. To apply, please send a CV, R01 research plan, and cover letter to Christian Renken. Deadline: 2010-12-31

Department of Health and Human Services. National Institutes of Health

Mechanisms, Models, Measurement, and Management in Pain Research (R01)

The purpose of this funding opportunity announcement (FOA), Mechanisms, Models, Measurement, and Management in Pain Research issued by the National Institute of Nursing Research, in conjunction with members of the National Institutes of Health Pain Consortium as listed above, is to inform the scientific community of the pain research interests of the various institutes and centers (ICs) at NIH and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with FOAs of identical scientific scope. The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. Applications for an R01 award are not limited in dollars but need to reflect the actual needs of the proposed project. Deadline: 2010-02-05; 2010-06-05; 2010-10-05

Department of Health and Human Services. National Institutes of Health

Mechanisms, Models, Measurement, and Management in Pain Research (R03)

The purpose of this funding opportunity announcement (FOA), Mechanisms, Models, Measurement, and Management in Pain Research, issued by the National Institute of Nursing Research, in conjunction with members of the National Institutes of Health Pain Consortium as listed above, is to inform the scientific community of the pain research interests of the various institutes and centers (ICs) at NIH and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. Budgets for direct costs of up to $50,000 per year and a project duration of up to 2 years may be requested for a maximum of $100,000 direct costs over a 2-year project period. Deadline: 2010-02-16; 2010-06-16; 2010-10-16

Department of Health and Human Services. National Institutes of Health

Mechanisms, Models, Measurement, and Management in Pain Research (R21)

The purpose of this funding opportunity announcement (FOA), Mechanisms, Models, Measurement, and Management in Pain Research, issued by the National Institute of Nursing Research, in conjunction with members of the National Institutes of Health Pain Consortium, is to inform the scientific community of the pain research interests of the various institutes and centers (ICs) at NIH and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-006, which encourages applications under the NIH R01 Research Project Grant mechanism, and PA-10-008, which encourages applications under the R03 Small Research Grant mechanism. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. Deadline: 2010-02-16; 2010-06-16; 2010-10-16

Department of Health and Human Services. National Institutes of Health

Comparing Design Approaches for Sequencing Disease-Associated Regions Found in Genome-Wide Association Studies (U01)

Genome-wide association studies (GWAS) have identified many genomic regions associated with common diseases and other traits. The next step is often to sequence many samples in the associated regions to determine their complete patterns of genetic variation. The goal is to identify a smaller set of strongly associated variants for more intense study to find those responsible for the increased disease risk. Various design strategies could be used for the sequencing studies, such as sequencing exons or entire gene regions, and using samples from the extremes or the entire range of the phenotype distribution. However, the appropriate conditions for using particular design strategies are unknown. To gain insight into optimal study design, the National Human Genome Research Institute (NHGRI) will support several studies to sequence association regions completely in large GWAS cohorts to provide standard data sets and analyses that the research community can use to study how to design sequencing studies to follow up GWAS findings. This funding opportunity announcement (FOA) solicits applications from investigators with well-replicated disease associations to nominate association regions for sequencing and analysis and to provide a sufficient number of samples with genotype, phenotype, and exposure data sets from completed GWA studies. The sequencing capacity will be provided by NHGRI large-scale sequencing centers, using a broad design strategy that encompasses a number of more focused strategies. Funding for analysis of the sequence data will be provided by the Genes, Environment, and Health Initiative. The funded GWAS groups will work in a consortium with the sequencing centers and analysts to develop the broad design strategy, analyze the sequence data for the individual studies, and evaluate the various specific design strategies. It is anticipated that $750,000 total in fiscal year 2010 funds will be provided to support three to six awards. Sequencing capacity will be provided for at least three projects; if funds are provided by other institutes or centers, additional projects may be supported. An application submitted for this FOA may request a project period of 1 year and direct costs up to $150,000. Deadline: 2009-11-10

Department of Health and Human Services. National Institutes of Health

Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)

The National Institute of Neurological Disorders and Stroke (NINDS) invites new and competing renewal applications for the Morris K. Udall Centers of Excellence for Parkinson's Disease Research program. Proposed centers must involve multidisciplinary teams engaged in integrative basic, translational, and clinical research on Parkinson's disease (PD), with the primary objective of transforming this research into the development of new treatments. Investigations on related Parkinsonian disorders may be included, to the extent that these inform and/or expand research on PD. Accomplishment of the stated goals of the center, and of each project, must require substantial collaborative efforts and the utilization of common resource cores. All proposed centers must include a preclinical and/or clinical translational research project. In this context, preclinical translation is defined as pre-Investigational New Drug/Investigational Device Exemption stage research on potential therapeutic or diagnostic candidates. Clinical translational projects are early-stage projects in human subjects that are designed as first steps toward transformation of scientific discoveries arising from basic research, clinical research, or population studies into new modalities for the prevention, treatment, and cure of PD. All centers are required to have an administrative core; inclusion of other research and core components is flexible within stated budget limits. Inclusion of a clinical component, a clinical translational research project plus a clinical resource core, is encouraged, as is emphasis on training and public outreach activities. The Udall Center director must be an established leader in scientific research with visionary leadership skills and proven expertise in research project and personnel management. Eligible institutions must demonstrate commitment to and support for the establishment and continuation of the proposed Udall Center. Successful applicants will participate in a network of existing Udall Centers to foster the translation of new scientific findings and technological developments into novel treatments for PD. NINDS intends to support four centers through this announcement. The estimated total funds available are $9 million for fiscal year 2010. Awards issued under this funding opportunity announcement are contingent upon availability of funds. Applicants should request no more than $1 million direct costs per year (exclusive of facilities and administrative costs of subcontracts with collaborating institutions), unless an optional clinical component is proposed. Deadline: 2009-11-10

Department of Health and Human Services. National Institutes of Health

Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00)

This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health, solicits applications for the Pathway to Independence Award (K99/R00) in Cancer Nanotechnology Research. This initiative is an integral component of a broader program to continue the interactive NCI Alliance for Nanotechnology in Cancer (the Alliance). In addition to this initiative, the Alliance will consist of the Center for Nanotechnology Excellence, platform projects, and Cancer Nanotechnology Training Centers. The primary purpose of this Pathway to Independence Award Program is to increase and maintain a strong cohort of new, talented investigators focused on research in cancer nanotechnology. The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent research support at an earlier stage than is currently the norm. For this K99/R00 FOA, NCI has committed approximately $2 million in total costs for fiscal year 2010 and $10 million over a 5-year period. Approximately eight to 10 awards are expected to be made in connection with this FOA. Deadline: 2009-12-07

Environmental Protection Agency.

Approaches to Assessing Potential Food Allergy from Genetically Engineered Plants

The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results program, is issuing this request for applications for applied research on innovative or improved methods to predict whether a pesticide protein is a food allergen. Research to characterize the key factors that influence human immune responses to dietary proteins is needed in order to better assess potential food allergy from genetically engineered plants. Proposals are requested on the role of dose, route of sensitization, and/or the physicochemical properties of ingested proteins and their influence on the development of immune sensitization, oral tolerance, or the elicitation of allergic symptoms. Also of interest is how the food matrix and gastrointestinal environment in which proteins are ingested may affect these immune responses. The overall aim of the research program is to improve safety assessment for genetically engineered plants by enhancing the ability to estimate the potency of unknown proteins relative to known allergenic and nonallergenic proteins. Because there is no single, definitive test for determining the allergenic potential of novel pesticide proteins in the diet, risk assessment associated with the regulation of foods derived from modern biotechnology currently uses a "weight of evidence" approach. The research will contribute to improved methods for assessing the potential dietary allergenicity of pesticide proteins in genetically engineered plants. EPA plans to fund approximately four awards. Approximately $1.7 million total will be allocated for all awards. EPA will give up to $425,000 per award, including direct and indirect costs, with a maximum duration of 3 years. Cost-sharing is not required. Proposals with budgets exceeding the total award limits will not be considered. Deadline: 2010-01-07

Environmental Protection Agency.

National Clean Diesel Funding Assistance Program, FY 2009/2010 Request for Proposals (RFP)

The U.S. Environmental Protection Agency's (EPA's) National Clean Diesel Funding Assistance Program is soliciting proposals nationwide for projects that achieve significant reductions in diesel emissions in terms of tons of pollution produced and diesel emissions exposure, particularly from fleets operating in areas designated by the administrator as poor air quality areas. Eligible diesel emission reduction solutions include verified emission-control technologies such as retrofit devices, cleaner fuels, and engine upgrades, verified idle-reduction technologies, verified aerodynamic technologies and low-rolling resistance tires, certified engine repowers, and/or vehicle or equipment replacement. Eligible diesel vehicles, engines, and equipment may include buses, medium-duty or heavy-duty trucks, marine engines, locomotives and nonroad engines, equipment or vehicles used in construction, handling of cargo (including at a port or airport), agriculture, mining, or energy production (including stationary generators and pumps). The total estimated funding for this competitive opportunity is approximately $64 million, including all nontribal and tribal awards. EPA regional offices will award the assistance agreements for projects resulting from this announcement. The anticipated number of nontribal awards and eligible funding varies for each EPA regional office. EPA also anticipates awarding approximately five to 10 tribal assistance agreements depending on the quantity and quality of tribal proposals received and funding considerations. The minimum eligible funding request for tribal proposals is $30,000. Funding will be in the form of cooperative agreements or grants. Deadline: 2009-12-08

Environmental Protection Agency.

Clean Diesel Emerging Technologies Funding Assistance Program, FY 2009/2010 Request for Proposals (RFP)

The Environmental Protection Agency's (EPA's) Clean Diesel Emerging Technologies Funding Assistance Program is soliciting proposals nationwide for projects that achieve significant reductions in diesel emissions in terms of tons of pollution produced and diesel emissions exposure, particularly from fleets operating in areas designated by the administrator as poor air quality areas. Under this solicitation, the only eligible diesel emission reduction solutions that may be proposed are the use of emerging emission-control technologies as listed on the National Clean Diesel Campaign's Emerging Technologies List (http://www.epa.gov/otaq/diesel/prgemerglist.htm). The total estimated funding for this competitive opportunity is approximately $8 million. EPA anticipates awarding a total of six to 10 cooperative agreements ranging from $500,000 to $1.5 million, subject to the availability of funds and the quality of proposals received. Deadline: 2009-12-08

Merck Company Foundation.

United Negro College Fund-Merck Graduate Science Research Dissertation Fellowships

United Negro College Fund (UNCF)-Merck Graduate Science Research Dissertation Fellowships are intended to support African-American graduate students as they complete coursework, conduct research, and prepare the dissertation required for the doctoral degree in the biomedically relevant life or physical sciences. At least 12 Graduate Science Research Dissertation Fellowship awards will be made in 2010. Each award is up to a maximum of $52,000 and consists of a fellowship stipend of up to $42,000 for the award recipient and a research grant of up to $10,000. For administrative purposes, the awards will be made to the institution with which each award recipient is affiliated. Only institutions in the United States are eligible. As the awards are intended to be used to support graduate student stipends and research, no part of the awards may be used for indirect costs. Awards begin no earlier than 1 September 2010. The fellowship stipend of up to $42,000 is intended to cover a minimum of 12 months up to a maximum of 24 months of fellowship tenure. A maximum of $30,000 may be received per 12-month period. Applicants must be engaged in dissertation research and within 1 to 3 years of receiving the degree. All qualifying exams for candidacy for the degree must have been successfully completed before an award can be disbursed. Award recipients will be known as UNCF-Merck Graduate Fellows. Each fellow will be mentored by a Merck scientist. As part of the award, each fellow will be expected to make regular contact with his/her Merck mentor. Each fellow is also expected to present a progress report of his/her research results in the last half of their fellowship tenure at a Merck research facility. The cost of this visit will be underwritten by Merck and Co. Inc. A 2-page summary of research results must be submitted to UNCF at the end of the fellowship tenure. Each fellow is expected to notify UNCF upon receipt of his/her doctorate degree. Deadline: 2009-12-01

Merck Company Foundation.

United Negro College Fund-Merck Postdoctoral Science Research Fellowship

The United Negro College Fund (UNCF)-Merck Postdoctoral Science Research Fellowships are intended to provide support to African-American postgraduates to obtain postdoctoral training or continue to conduct postdoctoral, preprofessional research projects. At least 10 UNCF-Merck Postdoctoral Science Research Fellowship awards will be made in 2010. Each award is up to a maximum of $85,000 and consists of a fellowship stipend of up to $70,000 for the award recipient and a research grant of up to $15,000. For administrative purposes, the awards will be made to the institutions with which the award recipients are affiliated. Only institutions in the United States are eligible. As the awards are intended to be used to support the stipends and research of postdoctoral fellows, no part of the awards may be used for indirect costs. Awards will begin no earlier than 1 September 2010. The postdoctoral fellowship stipend of up to $70,000 is intended to support the award recipient for a minimum period of 12 months and up to a maximum period of 24 months of fellowship tenure. A maximum of $50,000 may be received in any 12-month period. Award recipients will be known as UNCF-Merck Postdoctoral Fellows. Each fellow will be mentored by a Merck scientist. As part of the award, the fellow is expected to make regular contact with the Merck mentor. The fellow is also required to visit the Merck Research Laboratories to present a progress report to the Merck research staff during the last half of their postdoctoral fellowship tenure. The cost of this visit will be underwritten by Merck and Co. Inc. A 2-page summary of research results must be submitted to UNCF at the end of the fellowship tenure. Deadline: 2009-12-01

National Aeronautics and Space Administration.

ROA 2009: A.3 Subsonic Rotary Wing Project (SSRW1)

The challenge of the Subsonic Rotary Wing project of the NASA Fundamental Aeronautics program is to develop validated physics-based multidisciplinary design and analysis tools for rotorcraft, integrated with technology development, enabling rotorcraft with advanced capabilities to fly as designed for any mission. Meeting this challenge will require innovative technologies and methods, with an emphasis on integrated, multidisciplinary, first-principle computational tools specifically applicable to the unique problems of rotary wing aircraft. The focus of the Subsonic Rotary Wing project of the Fundamental Aeronautics program is the civil utility of rotorcraft. Several facets will be addressed at the fundamental research level: 1) efficiency, including aerodynamic performance and structural weight; 2) productivity, which requires high speed, large payload, long range, and good maneuverability; and 3) environmental acceptance, particularly noise and handling qualities. Without intending to predict where the design process will lead when truly effective design and analysis tools are available, some very promising (and very challenging) configurations can be identified to drive the required fundamental research. The challenges faced in rotary wing aviation are among the most complex and demanding of any configuration: highly complex, three-dimensional rotor and fuselage structures, unsteady flows in speed regimes from low subsonic to high transonic, dynamically-stalled components, harsh operating environments, highly-loaded propulsion systems, and a vehicle that is statically unstable. The Subsonic Rotary Wing project will focus its research effort in the most persistent technical challenge areas in order to produce advances in prediction tool capability and technology. Deadline: 2009-11-20

New Student and Institutional Support Programs

Merck Company Foundation.

United Negro College Fund-Merck Undergraduate Science Research Scholarship Awards

The United Negro College Fund-Merck Undergraduate Science Research Scholarship Awards are intended to encourage the interest of African-American undergraduate students in furthering their science education and pursuing biomedical science careers by providing tuition support and opportunities for research experience in a state-of-the-art industrial laboratory. At least 15 Undergraduate Science Research Scholarship Awards will be made in 2010. Each award is up to a maximum of $35,000 that consists of a scholarship award of up to $25,000 and two summer research internship stipends totaling at least $10,000. For administrative purposes, the scholarship portion of the awards will be sent directly to the institutions of the award recipients. As the scholarship award is intended to support the award recipient's tuition, room and board, and billable fees, no part of the award may be used for indirect costs. Awards are not transferable and may not be used at institutions abroad. Awards will be distributed for a 1 September 2010 start date. Deadline: 2009-12-01

[ top ]

GrantsNet Express

GrantsNet Express offers a new listing each week by e-mail of science funding opportunities from private foundations and organizations, as well as new U.S. government science grant announcements.

Deadline Watch

Urgent mouse

(Image: comstock)

Southmoravian Centre for International Mobility.

Reintegration Grants

Deadline: 2009-10-25

Southmoravian Centre for International Mobility.

Incoming Grants

Deadline: 2009-10-25

Department of Health and Human Services. National Institutes of Health

Beta Cell Biology Consortium (U01)

Deadline: 2009-10-26

Department of Agriculture.

Tahoe Research Supported by SNPLMA Round 10

Deadline: 2009-10-26

Department of Health and Human Services. National Institutes of Health

2010 NIH Directors New Innovator Award Program (DP2)

Deadline: 2009-10-27

American Association for Cancer Research.

Pancreatic Cancer Action Network-AACR Career Development Awards

Deadline: 2009-10-28

American Association for Cancer Research.

Pancreatic Cancer Action Network-AACR Fellowship

Deadline: 2009-10-28

American Association for Cancer Research.

Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

Deadline: 2009-10-28

National Science Foundation.

Physics at the Information Frontier

Deadline: 2009-10-28

National Science Foundation.

Emerging Frontiers in Research and Innovation (EFRI)

Deadline: 2009-10-29

National Aeronautics and Space Administration.

A.2 Subsonic Fixed Wing (SSFW1) (Recovery Act)

Deadline: 2009-10-30

Department of Defense.

DoD Spinal Cord Injury Exploration-Hypothesis Development Awards

Deadline: 2009-10-30; 2009-11-20

National Academies.

Pakistan-U.S. Science and Technology Cooperation Program

Deadline: 2009-10-31

National Academies.

Pakistan-U.S. Science and Technology Cooperation Program

Deadline: 2009-10-31

Barth Syndrome Foundation.

Research Grant

Deadline: 2009-10-31

National Science Foundation.

Polymers

Deadline: 2009-10-31

National Science Foundation.

Electronic and Photonic Materials

Deadline: 2009-10-31

Barth Syndrome Foundation.

Research Grant

Deadline: 2009-10-31

National Science Foundation.

Condensed Matter Physics

Deadline: 2009-10-31

National Science Foundation.

Biomaterials

Deadline: 2009-10-31

Barth Syndrome Foundation.

Research Grant

Deadline: 2009-10-31

Alzheimer's Drug Discovery Foundation.

2010 ADDF/ LBDA Lewy Body Dementia Biomarker Research Award

Deadline: 2009-11-01

Partnership for Clean Competition.

Grant Pre-application

Deadline: 2009-11-01

Department of Health and Human Services. National Institutes of Health

AHRQ Grants for Health Services Research Dissertation Program (R36)

Deadline: 2009-11-01; 2010-02-01; 2010-05-01; 2010-08-01

National Oceanic and Atmospheric Administration (NOAA).

National Estuarine Research Reserve Graduate Research Fellowship Program FY 2010

Deadline: 2009-11-02

Department of Health and Human Services. National Institutes of Health

Resource Core Alcohol Research Centers (P30)

Deadline: 2009-11-02

Department of Health and Human Services. National Institutes of Health

Comprehensive Alcohol Research Centers (P60)

Deadline: 2009-11-02

National Science Foundation.

EPSCoR Research Infrastructure Improvement Program: Inter-Campus and Intra-Campus Cyber Connectivity

Deadline: 2009-11-02

Pew Charitable Trusts.

Pew Scholars Program in the Biomedical Sciences

Deadline: 2009-11-02

Department of Health and Human Services. National Institutes of Health

Dissecting the Early HIV Immune Response: A Systems Biology Approach (P01)

Deadline: 2009-11-02

Department of the Interior.

FY 2010 Louisiana Coastal Marine Institute

Deadline: 2009-11-02

Department of Health and Human Services. National Institutes of Health

Specialized Alcohol Research Centers (P50)

Deadline: 2009-11-02

Bill and Melinda Gates Foundation.

Grand Challenges: Explorations

Deadline: 2009-11-02

American Psychiatric Foundation.

Alexander Gralnick, M.D. Award for Research in Schizophrenia

Deadline: 2009-11-02

Department of Health and Human Services. National Institutes of Health

Summer Research Training in Aging for Medical Students (T35)

Deadline: 2009-11-03

National Science Foundation.

International Collaboration in Chemistry between US Investigators and their Counterparts Abroad

Deadline: 2009-11-03

National Science Foundation.

Topology

Deadline: 2009-11-03

Department of Health and Human Services. National Institutes of Health

Targeted Library Synthesis and Screening at Novel Targets for Potential Drug Addiction Treatments and Research Tools (R21/R33)

Deadline: 2009-11-04

Department of Health and Human Services. National Institutes of Health

B Cell Immunology Partnership Program For HIV-1 Vaccine Discovery (U19)

Deadline: 2009-11-04

Centers for Disease Control and Prevention.

Public Health Informatics Fellowship Program

Deadline: 2009-11-04

Department of Energy . Office of Science

Computational Biology and Bioinformatic Methods to Enable a Systems Biology Knowledgebase

Deadline: 2009-11-05

National Collegiate Inventors and Innovators Alliance.

BMEidea Competition Stipends

Deadline: 2009-11-06

Department of Energy.

Biological Systems Research on the Role of Microbial Communities in Carbon Cycling

Deadline: 2009-11-09

Department of Health and Human Services. National Institutes of Health

Biobehavioral Research Awards for Innovative New Scientists (BRAINS) (R01)

Deadline: 2009-11-09

Department of Health and Human Services. National Institutes of Health

Comparing Design Approaches for Sequencing Disease-Associated Regions found in Genome-Wide Association Studies (U01)

Deadline: 2009-11-10

Department of Health and Human Services. National Institutes of Health

Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50)

Deadline: 2009-11-10

National Science Foundation.

Materials World Network: Cooperative Activity in Materials Research between US Investigators and their Counterparts Abroad

Deadline: 2009-11-11

Department of Health and Human Services. National Institutes of Health

Nathan Shock Centers Of Excellence in Basic Biology of Aging (P30)

Deadline: 2009-11-12

National Science Foundation.

Research and Evaluation on Education in Science and Engineering

Deadline: 2009-11-12

Department of the Interior.

EDMAP - The Educational Component of the National Cooperative Geologic Mapping Program

Deadline: 2009-11-12

Technical Editing Co., Ltd..

TE Best Manuscript Awards

Deadline: 2009-11-15

National Science Foundation.

Applied Mathematics

Deadline: 2009-11-15

Department of Health and Human Services. National Institutes of Health

Community Networks Program (CNP) Centers for Reducing Cancer Disparities through Outreach, Research and Training (U54)

Deadline: 2009-11-15

Environmental Protection Agency.

Clean Air Research Centers

Deadline: 2009-11-16

Department of Health and Human Services. National Institutes of Health

Centers for Medical Countermeasures Against Radiation (U19)

Deadline: 2009-11-16

Department of Health and Human Services. National Institutes of Health

Ancillary Studies in Clinical Trials of CNS/PNS Disorders NINDS Accelerated Awards Program (R01)

Deadline: 2009-11-16

Department of Health and Human Services. National Institutes of Health

Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies (D43)

Deadline: 2009-11-17

Department of Housing and Urban Development.

Green and Healthy Homes and Technical Studies Program

Deadline: 2009-11-17

Department of Health and Human Services. National Institutes of Health

Non-Human Primate Heart/Lung Transplantation Tolerance (U01, U19)

Deadline: 2009-11-17

The Michael J. Fox Foundation for Parkinson's Research.

Neurotrophic Factor Therapies for Parkinson's Disease 2010

Deadline: 2009-11-18

Department of Defense.

FY09 DOD Lung Cancer Promising Clinician Research Award

Deadline: 2009-11-19

US Department of Defense.

FY09 DOD Lung Cancer Clinical Fellow Research Award

Deadline: 2009-11-19

Department of Defense.

FY09 DOD Lung Cancer Research Program Collaborative Translational Research Award

Deadline: 2009-11-19

National Aeronautics and Space Administration.

ROA 2009: A.3 Subsonic Rotary Wing Project (SSRW1)

Deadline: 2009-11-20

Department of Defense.

Department of Defense Peer Reviewed Orthopaedic Career Development Award

Deadline: 2009-11-20

GrantsNet Sponsorship

Sponsorship opportunities are now available on GrantsNet and GrantsNet Express. Please contact Daryl Anderson for more information.

[ top ]

Donisha Adams is the GrantsNet Program Associate.

10.1126/science.caredit.f20091023


rssBookmark this page